Geode Capital Management
CMTA

Geode Capital Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Geode Capital Management’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-41,041
Closed -$1.07M – 4289
2019
Q1 		$1.07M Buy
41,041
+403
+1% +$7.53K ﹤0.01% 3137
2018
Q4 		$477K Buy
40,638
+19,317
+91% +$240K ﹤0.01% 3393
2018
Q3 		$237K Buy
21,321
+235
+1% +$2.47K ﹤0.01% 3715
2018
Q2 		$277K Buy
21,086
+5,883
+39% +$95.3K ﹤0.01% 3625
2018
Q1 		$230K Hold
15,203
– – ﹤0.01% 3648
2017
Q4 		$288K Hold
15,203
– – ﹤0.01% 3553
2017
Q3 		$256K Buy
+15,203
New +$248K ﹤0.01% 3587

Geode Capital Management's CMTA Position: Q2 2019 in Review

Geode Capital Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 41,041 shares — an estimated $1.07M sold.

Geode Capital Management first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $1.07M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Geode Capital Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Geode Capital Management sold 41,041 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $1.07M.
  • Geode Capital Management first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
  • Geode Capital Management's Clementia Pharmaceuticals Inc. position peaked at $1.07M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.